Screener
Bio-Techne TECH Total Liabilities & Equity
Total Liabilities & Equity at other companies
Other financials
Where this comes from
Reported directly by Bio-Techne in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesAndStockholdersEquity.
The source filing: Bio-Techne’s 10-Q, filed May 6, 2026.
- Filed
- May 6, 2026, 4:31 PM EDT
- Fiscal quarter
- Q3 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001104659-26-056302
| Line item | March 31, 2026 / (unaudited) | June 30, 2025 |
|---|---|---|
| Shareholders’ equity: | ||
| Undesignated capital stock, no par; authorized 5,000,000 shares; none issued or outstanding | — | — |
| Common stock, par value $.01 per share; authorized 400,000,000; issued and outstanding 156,516,091 and 154,972,196 respectively | 1,565 | 1,550 |
| Additional paid-in capital | 1,005,403 | 911,089 |
| Retained earnings | 1,145,192 | 1,066,049 |
| Accumulated other comprehensive loss | (66,856) | (59,880) |
| Total shareholders’ equity | 2,085,304 | 1,918,808 |
| Total liabilities and shareholders’ equity | $2,550,601 | $2,557,868 |
Item 1. Condensed Consolidated Financial Statements (Unaudited)
FAQ
- What is Bio-Techne's total liabilities & equity?
- Bio-Techne (TECH) reported total liabilities & equity of $2.55B in Q1 2026.
- How has Bio-Techne's total liabilities & equity changed year-over-year?
- Bio-Techne's total liabilities & equity decreased by 3.5% year-over-year, from $2.64B to $2.55B.
- What is the long-term trend for Bio-Techne's total liabilities & equity?
- Over 4 years (2021 to 2025), Bio-Techne's total liabilities & equity has grown at a 3.1% compound annual growth rate (CAGR), from $2.26B to $2.56B.
- What does total liabilities & equity mean?
- Total assets = total liabilities + total equity. This must always balance — a fundamental accounting identity.
Ask your AI about Bio-Techne's total liabilities & equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude